Abstract

Human Gene TherapyVol. 21, No. 7 EditorialProstate Cancer Gene Therapy: Attempts to InnovateStefan Kochanek and Bernd GansbacherStefan KochanekDivision of Gene Therapy, University of Ulm, 89081 Ulm, Germany.Search for more papers by this author and Bernd GansbacherInstitute of Experimental Oncology and Therapy Research, Technical University of Munich, 81675 Munich, Germany.Search for more papers by this authorPublished Online:7 Jul 2010https://doi.org/10.1089/hum.2010.1216AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Prostate Cancer Gene Therapy: Attempts to Innovate." , 21(7), p. 791FiguresReferencesRelatedDetailsCited BySynthesis of Tat tagged and folate modified N-succinyl-chitosan self-assembly nanoparticles as a novel gene vectorInternational Journal of Biological Macromolecules, Vol. 72A universal gene carrier platform for treatment of human prostatic carcinoma by p53 transfectionBiomaterials, Vol. 35, No. 9Synthesis and preliminary cellular evaluation of phosphonium chitosan derivatives as novel non-viral vectorCarbohydrate Polymers, Vol. 97, No. 2Dendrimer Nanoscaffolds for Potential Theranostics of Prostate Cancer with a Focus on Radiochemistry24 January 2013 | Molecular Pharmaceutics, Vol. 10, No. 3Future Prospects in the Diagnosis and Management of Localized Prostate CancerThe Scientific World Journal, Vol. 2013Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy22 December 2011 | The Journal of Gene Medicine, Vol. 13, No. 12 Volume 21Issue 7Jul 2010 InformationCopyright 2010, Mary Ann Liebert, Inc.To cite this article:Stefan Kochanek and Bernd Gansbacher.Prostate Cancer Gene Therapy: Attempts to Innovate.Human Gene Therapy.Jul 2010.791-791.http://doi.org/10.1089/hum.2010.1216Published in Volume: 21 Issue 7: July 7, 2010PDF download

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call